Rchr
J-GLOBAL ID:202301018841491682
Update date: Jan. 30, 2024
KAWASAKI YOHEI
KAWASAKI YOHEI
Affiliation and department:
Job title:
Lecture
Research theme for competitive and other funds (8):
- 2022 - 2025 甲状腺がんにおける予後予測マーカーと新規治療開発のためのGPNMBの検討
- 2022 - 2025 Cancer progression-related translocation of gap junction protein into the Golgi apparatus – Elucidation of its molecular mechanism
- 2021 - 2025 頭頸部癌CD98hc陽性GPNMB陽性細胞は転移能をもつ癌幹細胞である。
- 2021 - 2024 CD147を中心とした頭頸部癌の炎症性微小環境と免疫チェックポイント阻害薬抵抗性
- 2018 - 2023 CD147を基軸とした頭頸部癌における炎症性微小環境の解明
- 2018 - 2022 CD98hc+/CD44v9+ is a new cancer stem cell and radiosensitivity marker
- 2015 - 2018 CD98 is the marker of cancer stem cell and radioresistance
- 2013 - 2015 Cancer stem cell marker CD44 isoform changes in head and neck squamous cell carcinoma to define the grade
Show all
Return to Previous Page